Raloxifene (Raloxifene) – Patient Information for the UK

Raloxifene is a medicine used to help prevent and treat certain bone-related problems and to reduce the risk of specific breast conditions in appropriate people. It belongs to a group of medicines called selective oestrogen receptor modulators (SERMs). Like all medicines, it has benefits and important safety considerations, including effects on blood clot risk.

This guide is written to be patient-friendly and UK-focused. It explains how raloxifene works, how it behaves in the body, what it is used for, how it is usually taken, and what to consider regarding interactions and lifestyle.

Basic product information

How raloxifene works (mechanism of action)

Raloxifene acts on oestrogen receptors, but it does not behave like natural oestrogen throughout the body. Instead, it works as a “selective” oestrogen receptor modulator—meaning it can have oestrogen-like effects in some tissues (such as bone) and anti-oestrogen-like effects in others (such as breast).

Effects in the body

• Bone: Helps slow bone breakdown, supporting bone strength and reducing the risk of fractures.
• Breast: May reduce stimulation of certain types of breast cancer cells that rely on oestrogen.
• Uterus: Typically does not stimulate the uterine lining to the same degree as oestrogen therapy.

Because it is a SERM, raloxifene is not suitable for everyone and is chosen based on your individual health risks and treatment goals.

What raloxifene is used for (indications)

In the UK, raloxifene is used mainly in postmenopausal people to:

• Osteoporosis treatment and prevention: Helps reduce the risk of vertebral (spine) fractures in people with postmenopausal osteoporosis. In some cases it is also used to help prevent osteoporosis-related bone loss.
• Breast cancer risk reduction: May reduce the risk of developing invasive breast cancer in people at risk, particularly where the cancer is oestrogen receptor positive (depending on clinical assessment).

Your clinician may consider raloxifene when it fits your risk profile—especially if maintaining bone health is important and certain breast-cancer-risk factors exist.

Typical timing and how to take raloxifene

When to take it

• Once daily is the common schedule.
• Try to take it at a similar time each day to help you remember.

How to take it

• Swallow the tablet whole with water.
• You can generally take raloxifene with or without food (see food notes below).
• Continue taking it consistently for long-term benefits (bone protection and cancer-risk reduction rely on ongoing use).

If you miss a dose

If you miss a dose, take it as soon as you remember unless it is close to the time of your next dose. Do not take a double dose to make up for a missed tablet. If you are unsure, ask a healthcare professional or follow the patient information leaflet.

Suggested dosing (general information)

Dosing can vary depending on the exact product and your condition. As a general rule for postmenopausal use, raloxifene is often prescribed as a once-daily tablet dose.

Important: Always follow the dose recommended for you by a healthcare professional and the instructions in the product leaflet.

Dose adjustments

• Liver impairment: Raloxifene may require extra caution. Inform your clinician if you have liver disease.
• Kidney impairment: Use may be guided by kidney function and clinical judgement.
• Drug interactions: Some medicines can affect how well raloxifene works or increase side effects.

Pharmacokinetics: how raloxifene moves through the body

Pharmacokinetics describes how the body absorbs, distributes, metabolises, and eliminates a medicine. The following is a patient-friendly summary of what matters clinically.

Absorption

After oral dosing, raloxifene is absorbed and reaches peak concentration in the bloodstream within a few hours (timing may vary between people).

Distribution

Raloxifene binds significantly to proteins in the blood. It then distributes to tissues that have relevant oestrogen receptors.

Metabolism

Raloxifene is metabolised mainly in the liver. It also undergoes enterohepatic circulation (meaning part of the drug can be reprocessed and recycled through the digestive tract), contributing to its overall effect over time.

Elimination (half-life)

Raloxifene has a relatively long half-life, allowing once-daily dosing for many indications. It is eliminated mainly via the faeces, with a smaller amount via urine.

Because it persists in the body, stopping and starting can change how long the medicine’s effects remain. Always follow the clinician’s plan.

Food interactions: can you take raloxifene with meals?

In most cases, raloxifene can be taken with or without food. Food is not generally expected to cause a clinically significant change in overall effectiveness.

Practical advice

• Choose a routine that helps you take it consistently.
• If you experience stomach upset or nausea, consider taking it with food.
• If you have dietary restrictions or long-term conditions, discuss them with a healthcare professional.

Alcohol and raloxifene

There is no single universal “no alcohol ever” rule for raloxifene, but alcohol can affect overall health in ways that may matter for safety. Alcohol may:

• Increase the risk of falls or dizziness (important for anyone with osteoporosis risk).
• Worsen liver-related concerns in people with existing liver problems.
• Interact indirectly with other medications you take.

If you drink alcohol, consider keeping it moderate and consistent with any advice you have from your healthcare professional—especially if you have liver disease or take other medicines that affect clotting, mood, or dizziness.

Medicine interactions: what to consider

Interactions depend on your personal medicines list. Always tell a healthcare professional or pharmacist about: all medicines, including over-the-counter products and herbal supplements.

Common interaction themes

• Hormonal therapies: Other oestrogen-containing treatments (or certain hormone preparations) may change the benefit/risk balance.
• Medicines that affect blood clot risk: Combining medicines that also raise clot risk may increase the likelihood of thromboembolic events.
• Drugs affecting liver enzymes: Since raloxifene is metabolised in the liver, some medicines may influence levels.

Examples you should discuss

The list below is not exhaustive. It is included to help you think about what to check with a pharmacist:

• Anticoagulants/antiplatelets: Used for clot prevention or other heart conditions—ask how they fit with your overall risk.
• Other bone medicines: Such as bisphosphonates or calcium/vitamin D—often used together, but it should be planned.
• Other breast cancer or hormone treatments: Combination strategies require careful specialist guidance.
• Herbal products: Some supplements can affect metabolism or clotting indirectly.

If you have had clotting problems before (deep vein thrombosis, pulmonary embolism) or a stroke, discuss this before starting raloxifene.

Safety profile: important risks and side effects

Most medicines can cause side effects. With raloxifene, it’s especially important to understand the blood clot risk and when urgent help is needed.

Common side effects

• Hot flushes or sudden warmth
• Leg cramps
• Headache
• Nausea
• Flu-like symptoms or tiredness in some people
• Swelling (oedema) in some cases

Serious side effects (seek urgent advice)

Raloxifene may increase the risk of venous thromboembolism (for example, deep vein thrombosis or pulmonary embolism). In some people, it may also increase certain stroke-related risks depending on overall cardiovascular status.

• Symptoms of blood clots:
  • Swelling, pain, warmth or redness in one leg
  • Sudden shortness of breath
  • Chest pain that may worsen with breathing
• Stroke warning signs:
  • Sudden face drooping
  • Arm weakness (often one side)
  • Speech difficulty
  • Sudden severe headache or loss of balance

If you suspect a clot or stroke, get urgent medical attention immediately.

Who should take extra care?

• History of blood clots (DVT/PE) or known clotting disorders
• Recent surgery or prolonged immobility (e.g., long bed rest)
• Known cardiovascular risk factors, depending on clinician assessment
• People with unexplained vaginal bleeding should be assessed promptly

Practical use tips

Adherence and bone health

• Take it every day at a consistent time.
• Use a weekly pill organiser or reminders to reduce missed doses.
• Continue recommended lifestyle support for bone health (weight-bearing activity where safe, adequate calcium/vitamin D intake if advised).

When you may need additional precautions

• Planned surgery or long travel: Discuss your medicines in advance. Prolonged immobility can increase clot risk generally.
• Illness with reduced mobility: If you become less mobile for several days, speak to a healthcare professional about whether any temporary changes are needed.

Monitoring

Unlike some medicines, raloxifene does not usually require routine blood monitoring. However, your clinician may review: fracture risk, overall cardiovascular risk, and side effects.

Alternative options for osteoporosis and breast cancer risk reduction

If raloxifene is not suitable (for example, due to clot risk, intolerance, or different treatment goals), there are alternative approaches. Choice depends on your specific health profile.

Bone (osteoporosis) alternatives

• Bisphosphonates (e.g., alendronic acid, risedronate, zoledronic acid)
• Denosumab (an injectable medicine)
• Other SERMs (not all have the same profile)
• Hormone replacement therapy (HRT) in selected cases, with specialist consideration
• Calcium and vitamin D supplementation if intake is low (often used alongside other therapies)

Breast cancer risk reduction alternatives

• Other hormone-modulating strategies that may be considered based on receptor status and risk category
• Enhanced surveillance (screening and risk assessment) where appropriate
• In some cases, medicines used for prevention after specialist evaluation

Your clinician can explain which option is most appropriate based on your fracture risk, cardiovascular risk, and personal preferences.

Raloxifene in the UK: market and legal context, and recent guidance

In the United Kingdom, medicines such as raloxifene are regulated under the Medicines and Healthcare products Regulatory Agency (MHRA). Information about authorised indications, contraindications, and safety updates is supported by the product’s approved Summary of Product Characteristics and the patient information leaflet provided with the medicine.

Recent guidance relevant to medicines in this class may include ongoing safety reviews relating to cardiovascular and thromboembolic risk. Clinical practice also continues to follow evidence-based osteoporosis guidance and UK-fracture prevention strategies.

Because guidance can evolve, it’s important to use the most up-to-date information in your leaflet and to discuss suitability with a healthcare professional, particularly if you have risk factors for blood clots or stroke.

Delivery and availability in the UK

Availability can vary depending on the pharmacy supplier and current stock levels. Many UK pharmacies can deliver medicines to eligible addresses with standard and express options depending on the service.

What to expect when ordering

• Clear product details (strength, quantity, and manufacturer)
• Packaging suitable for safe delivery
• Delivery times depending on your location
• Discreet packaging as standard with many services

If you need the medicine urgently (e.g., you are starting or continuing a course), check estimated dispatch and delivery timelines shown at checkout.

Safety checklist before starting (helpful for patients)

Consider checking the following with your pharmacist or clinician:

• Are you postmenopausal and taking raloxifene for an appropriate indication?
• Do you have a history of blood clots, pulmonary embolism, or stroke?
• Will you have surgery soon or will you be immobile for long periods?
• Are you currently using any hormone-related treatments or medicines affecting clotting?
• Do you have unexplained vaginal bleeding or any unusual symptoms needing review?

FAQ: Frequently asked questions

1) Is raloxifene the same as oestrogen?

No. Raloxifene is a SERM. It can act like oestrogen in some tissues (especially bone) but has anti-oestrogen effects in other tissues (such as breast). It is not the same as taking natural oestrogen or HRT.

2) Will raloxifene stop hot flushes?

Some people may notice changes in hot flushes, but raloxifene can also cause hot flushes as a side effect. If hot flushes are troublesome, discuss options with your healthcare professional.

3) How long does it take to work?

Bone-related benefits develop over time with ongoing use. Your clinician may review your fracture risk periodically. Cancer-risk reduction is also based on consistent long-term use.

4) Can I take raloxifene with calcium and vitamin D?

Often, yes—calcium and vitamin D are commonly recommended for bone health. Whether and how to combine depends on your diet, blood levels, and the overall osteoporosis plan. Your pharmacist or clinician can help you confirm what is appropriate for you.

5) Does food affect raloxifene?

Usually not significantly. You can generally take raloxifene with or without food. If you feel nausea, taking it with a meal may help.

6) What should I do if I have leg swelling or sudden shortness of breath?

These could be signs of a blood clot. Seek urgent medical care immediately. Do not wait for symptoms to pass.

7) Can I drink alcohol while taking raloxifene?

Moderate alcohol may be acceptable for some people, but alcohol can increase fall risk and may not be ideal if you have liver issues. It’s safest to follow advice from your clinician and keep drinking moderate.

8) What if I’m travelling long distances?

Long travel can increase general clot risk due to reduced movement. Consider staying mobile, doing leg exercises, and discussing whether any additional precautions are necessary for you while taking raloxifene.

9) Are there alternatives if I cannot take raloxifene?

Yes. There are other options for osteoporosis (such as bisphosphonates or denosumab) and other strategies for breast cancer risk reduction. The best choice depends on your medical history and risk factors.

10) Where can I find the most accurate instructions?

Always read the patient information leaflet provided with your specific raloxifene product. If anything is unclear, speak to a pharmacist.

Summary

Raloxifene is a SERM used in postmenopausal people for osteoporosis management and to reduce the risk of certain breast cancers. It supports bone health by acting on oestrogen receptors in bone, but it is not free of important risks—particularly the possibility of blood clots and cardiovascular considerations in certain individuals.

If you have risk factors such as a history of clots or stroke, are planning surgery, or have concerns about side effects or interactions, talk to a healthcare professional before and during treatment.